SCHEMBL31371876

SCHEMBL31371876

CC(C)c1ccc(OCC(F)F)c(S(=O)(=O)Cl)c1

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 9/20 0.43
▸ SMN1; SMN2 Q16637 3/20 0.43
▸ TSHR P16473 3/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ TRPV4 Q9HBA0 1/20 0.42
▸ ALPL P05186 1/20 0.40
▸ HPGD P15428 1/20 0.39
▸ POLB P06746 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ ACHE P22303 2/20 0.35
▸ BCHE P06276 1/20 0.35
▸ RECQL P46063 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ HTR2A P28223 1/20 0.34
▸ HTR2C P28335 1/20 0.34
▸ HTR2B P41595 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL741127 0.84 ALDH1A1 (0.59) ALDH1A1SMN1; SMN2TSHRKMT2ATRPV4
SCHEMBL24314301 0.82 ALDH1A1 (0.43) ALDH1A1SMN1; SMN2TSHRKMT2ATRPV4
SCHEMBL10641518 0.79 ALDH1A1 (0.57) ALDH1A1SMN1; SMN2TSHRTRPV4HPGD
SCHEMBL24313621 0.78 GLRA1 (0.44) ALDH1A1SMN1; SMN2TSHRKMT2AALPL
SCHEMBL24313728 0.78 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2TSHRKMT2AALPL
SCHEMBL29469921 0.78 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2TSHRKMT2AALPL
SCHEMBL24314213 0.77 ALDH1A1 (0.41) ALDH1A1SMN1; SMN2TSHRKMT2AALPL
SCHEMBL18118612 0.74 ACHE (0.40) SMN1; SMN2ACHEBCHENPSR1HTR2A
SCHEMBL31535977 0.74 TRPV4 (0.56) ALDH1A1SMN1; SMN2TSHRTRPV4HPGD
SCHEMBL31372046 0.74 ACHE (0.37) ALDH1A1SMN1; SMN2ACHEBCHEHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025036382-A1 SULFONAMIDE COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF 上海复宏汉霖生物医药有限公司 2025-02-20 — — WO disclosed
Send feedback